1. Denmeade, S. R. and Isaacs, J. T. (2002) A history of prostate cancer treatment. Nat. Rev. Cancer 2, 389–396.
2. Isaacs, W., De Marzo, A., and Nelson, W. G. (2002) Focus on prostate cancer. Cancer Cell 2, 113–116.
3. Jarrard, D. F., Kinoshita, H., Shi, Y., et al. (1998) Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res. 58, 5310–5314.
4. Culig, Z., Hobisch, A., Cronauer, M. V., et al. (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474–5478.
5. Hobisch, A., Eder, I. E., Putz, T., et al. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res. 58, 4640–4645.